to all nervous nellies out there thinking to put a stop loss in,...

to all nervous nellies out there thinking to put a stop loss in, think carefully. Tree shaking, games and more tree shaking. I got very badly burned with Dendreon few years ago when it was forced down to $7 from $27 only to rebound and rise to new highs into the $30s.

Stop losses are not always your friend.

To all long termers, have confidence in all time consuming research you did, Hotcopper banter your partook in and the time you locked your funds in to PRR, all time spent trusting in CVAC - perhaps for years.

- Orphan Drug Designation
- Fast track to FDA approval
- Massive unmet need
- No serious competition
- Track ahead cleared by DNDN
- Lots of lessons learned from DNDN
- Unique t-cell activation approach in CVAC
- Multiple mucin-1 cancers potential
- Involvement from top world reknowned scientist Professor Ian Frazer
- Highly respected brother Dr Neil Frazer hired as Chief Medical Officer
- Lucy Turnbull chairman (why would she be involved knowingly in a dud?)

The list goes on.

CVAC has EVERY chance to go to market within a few years.

This is only the beginning.

Go PRR

GLTA

DYOR and trust your gut instinct